Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia

This study has been completed.

Study NCT00086593 Information provided by GlaxoSmithKline

First Received: July 6, 2004 Last Updated: March 17, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given